Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
Rui Qin, Haibo Ni, Di Li, et al.
Current Neuropharmacology (2018) Vol. 16, Iss. 9, pp. 1348-1357
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

The Role of Oxidative Stress in Parkinson’s Disease
Kuo‐Hsuan Chang, Chiung‐Mei Chen
Antioxidants (2020) Vol. 9, Iss. 7, pp. 597-597
Open Access | Times Cited: 226
Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action
Paolo Bellavite
Antioxidants (2023) Vol. 12, Iss. 2, pp. 280-280
Open Access | Times Cited: 79
The autophagy–NAD axis in longevity and disease
Niall Wilson, Tetsushi Kataura, Miriam E. Korsgen, et al.
Trends in Cell Biology (2023) Vol. 33, Iss. 9, pp. 788-802
Open Access | Times Cited: 56
Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72
Carl Laflamme, Paul M. McKeever, Rahul Kumar, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 130
PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
Wen Li, Yuhong Fu, Glenda M. Halliday, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 68
Preventing Parkinson’s Disease: An Environmental Agenda
Briana R. De Miranda, Samuel M. Goldman, Gary W. Miller, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 45-68
Open Access | Times Cited: 66
Zebrafish as a model organism for neurodegenerative disease
Kelda Chia, Anna Klingseisen, Dirk Sieger, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 65
Nuclear factor‐kappa B (NF‐κB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration
Mahsa Dolatshahi, Mohammad Hossein Ranjbar Hameghavandi, Mohammadmahdi Sabahi, et al.
European Journal of Neuroscience (2021) Vol. 54, Iss. 1, pp. 4101-4123
Closed Access | Times Cited: 57
The Promise of the Zebrafish Model for Parkinson’s Disease: Today’s Science and Tomorrow’s Treatment
Khairiah Razali, Noratikah Othman, Mohd Hamzah Mohd Nasir, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 56
Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer’s, Parkinson’s, and Huntington’s Diseases and Amyotrophic Lateral Sclerosis
Alexandru Vlad Ciurea, Aurel George Mohan, Razvan-Adrian Covache-Busuioc, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10809-10809
Open Access | Times Cited: 37
Sex and Gender Differences in Parkinson's Disease
Roshni Patel, Katie Kompoliti
Neurologic Clinics (2023) Vol. 41, Iss. 2, pp. 371-379
Closed Access | Times Cited: 35
LRRK2 and Parkinson's disease: from genetics to targeted therapy
Yuri L. Sosero, Ziv Gan‐Or
Annals of Clinical and Translational Neurology (2023) Vol. 10, Iss. 6, pp. 850-864
Open Access | Times Cited: 30
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease
Marco Hadisurya, Li Li, Kananart Kuwaranancharoen, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 26
Plant-derived exosomes as cell homogeneous nanoplatforms for brain biomacromolecules delivery ameliorate mitochondrial dysfunction against Parkinson’s disease
Yang Xu, Ge Yan, Jingyu Zhao, et al.
Nano Today (2024) Vol. 58, pp. 102438-102438
Closed Access | Times Cited: 13
Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches
Zeba Firdaus, Xiaogang Li
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2320-2320
Open Access | Times Cited: 11
Experimental models of Parkinson’s disease: Challenges and Opportunities
Roshan Lal, Aditi Singh, S. Watts, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176819-176819
Closed Access | Times Cited: 10
Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples
Steven C. Pike, Matthew C. Havrda, Francesca Gilli, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
Yunying Yang, Zhentao Zhang
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 61
New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
Marina Lorente Picón, Ariadna Laguna
Biomolecules (2021) Vol. 11, Iss. 3, pp. 433-433
Open Access | Times Cited: 51
Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
Tapan Behl, Piyush Madaan, Aayush Sehgal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10161-10161
Open Access | Times Cited: 46
The Role of DNA Damage in Neural Plasticity in Physiology and Neurodegeneration
Anna Konopka, Julie D. Atkin
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 37
Vascular smooth muscle cell dysfunction in neurodegeneration
Genevieve Hayes, Joana Pinto, Sierra Sparks, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 33
Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures
Rekha Dhanwani, João Rodrigues Lima-Júnior, Ashu Sethi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 29
The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology
Julia Obergasteiger, Anne-Marie Castonguay, Sara Pizzi, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top